What Is Dual Diagnosis?

Dual diagnosis — also called co-occurring disorders — refers to the simultaneous presence of a substance use disorder and one or more mental health conditions. The term was introduced in the 1980s to describe patients who didn't fit neatly into either the mental health system or the addiction treatment system, but needed both.

According to SAMHSA's 2023 National Survey on Drug Use and Health, approximately 21.5 million Americans have co-occurring substance use and mental health disorders. Yet only a fraction receive integrated treatment for both conditions. The historical practice of treating these conditions sequentially — first address the addiction, then the mental health — has been repeatedly shown to produce inferior outcomes compared to integrated treatment.

The relationship between addiction and mental health disorders is complex and bidirectional. Mental health conditions can drive substance use (self-medication hypothesis), substance use can cause or worsen mental health symptoms (neurobiological effects), and shared genetic and environmental vulnerabilities can cause both to emerge simultaneously. This complexity means that effective treatment must address both disorders together, in an integrated clinical model.

Common Co-Occurring Mental Health Conditions

Any mental health condition can co-occur with addiction, but certain conditions are particularly common in people with substance use disorders:

Why Integrated Treatment Is Essential

For decades, the standard approach was sequential treatment: complete addiction treatment first, then address mental health. Research has conclusively shown this approach fails most patients with co-occurring disorders. Here's why integrated treatment is the clinical standard:

Untreated Mental Health Drives Relapse

When a person with PTSD completes addiction treatment but their trauma remains unaddressed, the psychological pain that originally drove their substance use remains. Without the substance, they face that pain without any coping mechanism. The relapse risk is enormous. NIDA research demonstrates that people with untreated co-occurring mental health conditions are twice as likely to relapse within 12 months compared to those who receive integrated treatment.

Substances Mask Psychiatric Symptoms

Active substance use can mask, mimic, or worsen psychiatric symptoms — making accurate diagnosis nearly impossible. A patient in active alcohol use may present with severe depression that resolves with sobriety, or the opposite: a patient whose apparent "stimulant-induced psychosis" is actually an underlying schizophrenia spectrum disorder. Integrated dual diagnosis treatment allows the clinical team to observe psychiatric symptoms across the full context of stabilization, providing more accurate diagnosis and treatment.

Shared Neurobiological Mechanisms

Addiction and many mental health conditions share underlying neurobiological pathways — dopamine dysregulation, HPA axis dysfunction, prefrontal cortex impairment, and altered reward processing. Treatments targeting these shared mechanisms can address both conditions simultaneously. For example, certain antidepressants have demonstrated effectiveness for both depression and alcohol use disorder, and trauma-focused therapies like EMDR simultaneously reduce PTSD symptoms and substance cravings.

What Dual Diagnosis Treatment Looks Like

Integrated dual diagnosis treatment delivers addiction and mental health services simultaneously through the same clinical team. Core components include:

Comprehensive Psychiatric Assessment

A licensed psychiatrist conducts a thorough psychiatric evaluation — distinct from a standard addiction assessment — including structured diagnostic interviews, trauma screening, suicide risk assessment, and mental status examination. This evaluation occurs after an initial stabilization period to allow acute substance effects to clear, enabling more accurate diagnosis.

Integrated Individual Therapy

Individual therapy in dual diagnosis programs uses modalities specifically validated for co-occurring disorders. CBT has strong evidence for both addiction and depression/anxiety. DBT — developed specifically for emotion dysregulation — is particularly effective for BPD, PTSD, and addiction simultaneously. EMDR processes traumatic memories that drive both PTSD symptoms and substance use cravings. Acceptance and Commitment Therapy (ACT) builds psychological flexibility applicable to both conditions.

Psychiatric Medication Management

When indicated, psychiatric medications are prescribed and monitored by the treatment team's psychiatrist. For depression, SSRIs and SNRIs may be appropriate. For bipolar disorder, mood stabilizers (lithium, valproate, lamotrigine) are often indicated. For PTSD, SSRIs and prazosin for nightmares may be used. For ADHD, stimulant medications may be prescribed with careful monitoring. Medication-Assisted Treatment (MAT) for opioid or alcohol use disorder is also fully integrated — not managed separately.

Trauma-Informed Care

Given the high prevalence of trauma among people with addiction and co-occurring disorders, all staff in integrated programs are trained in trauma-informed care principles. This means treatment is delivered with awareness of trauma's pervasive effects, practices that avoid re-traumatization, and specific trauma-processing therapies for patients who are clinically ready. Programs following SAMHSA's Seeking Safety curriculum have demonstrated effectiveness for co-occurring PTSD and substance use.

Co-Occurring Groups

Specialized group therapy sessions address the intersection of addiction and specific mental health conditions. Examples include: trauma recovery groups, anxiety management groups, mood disorder management groups, and DBT skills groups. These groups allow patients with similar co-occurring presentations to work through shared challenges together under clinical facilitation.

Dual Diagnosis at Every Level of Care

Dual diagnosis treatment is available across the full continuum of care. The appropriate level depends on the severity of both the addiction and the mental health condition:

• Inpatient / Residential: For severe psychiatric instability alongside severe addiction — 24/7 monitoring, daily psychiatric contact, intensive integrated programming
• Partial Hospitalization (PHP): For stabilized but significant co-occurring conditions — 30+ hrs/week with psychiatric services integrated
• Intensive Outpatient (IOP): For patients with stable but present co-occurring conditions who need structured outpatient support
• Standard Outpatient: For ongoing psychiatric follow-up and therapy in long-term recovery maintenance

Dual Diagnosis and Insurance Coverage

Dual diagnosis treatment is covered under both addiction treatment benefits and mental health benefits under the Mental Health Parity and Addiction Equity Act. Most insurance plans must cover integrated dual diagnosis care at a level comparable to general medical care. Coverage includes psychiatric evaluation, medication management, individual therapy, group therapy, and all levels of intensive care.

• Private insurance: BCBS, UnitedHealthcare, Aetna, Cigna, and Anthem all cover dual diagnosis treatment under MHPAEA.
• Medicaid: Covers integrated dual diagnosis care in all 50 states — often at $0 for qualifying members.
• Medicare: Parts A and B cover psychiatric evaluation, medication management, and outpatient mental health treatment alongside addiction care.
• TRICARE: Covers dual diagnosis treatment — particularly important given the high rates of PTSD and co-occurring SUD among veterans and active duty service members.

Call (844) 561-0606 and we will verify your specific dual diagnosis treatment benefits and connect you with integrated programs that accept your insurance — at no cost to you.

Frequently Asked Questions About Dual Diagnosis